Synergistic enhancement of AAV gene delivery in 2D cells and 3D organoids using polybrene and hydroxychloroquine
PLOS One · 2025
DOI: 10.1371/journal.pone.0336164 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Hyeon-Jin Na und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gene and Cell Therapy, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Dependovirus, Hydroxychloroquine, Organoids, Gene Transfer Techniques. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea, National Research Council of Science & Technology.
Abstract (Originalsprache)
Recent advances in three-dimensional (3D) culture platforms have enabled organoids to serve as physiologically relevant models for recapitulating human biology and assessing therapeutic efficacy and toxicity. Despite their promise, their complex architecture presents significant challenges for efficient gene delivery, thereby limiting their broader application in drug discovery and translational research. To overcome this challenge, we developed a sequential treatment strategy that combines polybrene (PB), which facilitates viral entry, and hydroxychloroquine (HCQ), which modulates endosomal processing. By applying PB as a pre-treatment and HCQ as a post-treatment, we achieved an approximate 1.3- to 2-fold increase in adeno-associated virus (AAV) transduction efficiency in both retinal and liver organoid models compared to single-agent treatments, and a 1.7- to 2.5-fold increases compared to treatment with virus alone. Importantly, this combinatorial treatment preserved cellular integrity, as confirmed by minimal TUNEL assay and high overall viability. Our findings demonstrate that sequential administration of PB and HCQ significantly improves AAV transduction in 3D retinal and liver organoid systems, offering a robust method to improve gene delivery. This approach not only overcomes current limitations in organoid-based research but also supports the development of more predictive platforms for evaluating AAV vectors and advancing gene therapy applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Gene and Cell Therapy, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
- Department of Advanced Bioconvergence, Korea University of Science and Technology, Daejeon, Republic of Korea.
- Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
ORCID-Profile: Hyeon-Jin Na, Seung-Hyun Kim, Seung Pil Jang, Yong Min Choi, Kyung-Sook Chung
Förderung
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea
- National Research Council of Science & Technology
Zitieren
APA
Na, H. J., Shin, Y., Kim, S. H., Jang, S. P., Son, M. J., Choi, Y. M., Jeon, H. G., Kwon, O. S., & Chung, K. S. (2025). Synergistic enhancement of AAV gene delivery in 2D cells and 3D organoids using polybrene and hydroxychloroquine. PLOS One. https://doi.org/10.1371/journal.pone.0336164
Vancouver
Na HJ, Shin Y, Kim SH, Jang SP, Son MJ, Choi YM, et al. Synergistic enhancement of AAV gene delivery in 2D cells and 3D organoids using polybrene and hydroxychloroquine. PLOS One. 2025. doi:10.1371/journal.pone.0336164
BibTeX
@article{Na2025,
author = {Na, Hyeon-Jin and Shin, Yongbo and Kim, Seung-Hyun and Jang, Seung Pil and Son, Myung Jin and Choi, Yong Min and Jeon, Hyeon Gyeol and Kwon, Ok-Seon and Chung, Kyung-Sook},
title = {Synergistic enhancement of AAV gene delivery in 2D cells and 3D organoids using polybrene and hydroxychloroquine},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336164}
}
EUVIMED